CHITTUR RAMANATHAN: Open Payments
NPI 1538155288 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 14 payments from 8 companies in 2025. Trend: 2023 $589 · 2024 $332 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Novo Nordisk Inc | 3 | $53 |
| Lilly USA, LLC | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Ardelyx, Inc. | 1 | $29 |
| Medtronic, Inc. | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
Products named: Kerendia, MOUNJARO, JARDIANCE, Ozempic, IBSRELA, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
